Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

A Modified Direct-Smear Processing Technique Employing Two-Step Centrifugation/Fixation Is Useful for Detecting High-Grade Urothelial Carcinoma.

Toyonaga Y, Yamazaki K, Koyama Y, Yamada M, Ishida Y.

Acta Cytol. 2017;61(6):447-454. doi: 10.1159/000480062. Epub 2017 Sep 28.

PMID:
28954257
2.

Impact of systemic inflammatory response syndrome and surgical Apgar score on post-operative acute kidney injury.

Toyonaga Y, Asayama K, Maehara Y.

Acta Anaesthesiol Scand. 2017 Nov;61(10):1253-1261. doi: 10.1111/aas.12965. Epub 2017 Aug 28.

PMID:
28849594
3.

Serotype replacement of Streptococcus pneumoniae due to seven-valent pneumococcal conjugate vaccine in Japan.

Sakata H, Sato Y, Toyonaga Y, Hanaki H; Drug-Resistant Pathogen Surveillance Group in Pediatric Infectious Disease.

Pediatr Int. 2018 Jan;60(1):52-56. doi: 10.1111/ped.13386. Epub 2017 Oct 3.

PMID:
28779495
4.

[Efficacy and Indication of Fibrinogen Replacement Therapy in Thoracic Aortic Surgery A Retrospective Cohort Study].

Kikura M, Tobetto Y, Uehara H, Toyonaga Y, Kato M, Suzuki Y, Kojima Y, Go R.

Masui. 2017 Apr;66(4):376-382. Japanese.

PMID:
30382635
5.

Concise SAR Exploration Based on the "Head-to-Tail" Approach: Discovery of PI4KIII╬▒ Inhibitors Bearing Diverse Scaffolds.

Noji S, Seki N, Maeba T, Sakai T, Watanabe E, Maeda K, Fukushima K, Noguchi T, Ogawa K, Toyonaga Y, Negoro T, Kawasaki H, Shiozaki M.

ACS Med Chem Lett. 2016 Aug 3;7(10):919-923. eCollection 2016 Oct 13.

6.

Hyperchloremic acidosis is associated with acute kidney injury after abdominal surgery.

Toyonaga Y, Kikura M.

Nephrology (Carlton). 2017 Sep;22(9):720-727. doi: 10.1111/nep.12840.

PMID:
27312130
7.

[Cytoreductive Surgery Performed Twice for Pseudomyxoma Peritonei with Pleural Extension of Mucinous Tumor].

Ito T, Yasuma F, Toyonaga Y, Kobayashi Y, Shinohara A, Furuya M, Shiga Y, Maehara Y.

Masui. 2015 Jun;64(6):655-9. Japanese.

PMID:
26437560
8.

Nationwide survey of Streptococcus pneumoniae drug resistance in the pediatric field in Japan.

Okada T, Sato Y, Toyonaga Y, Hanaki H, Sunakawa K.

Pediatr Int. 2016 Mar;58(3):192-201. doi: 10.1111/ped.12781. Epub 2016 Feb 19.

PMID:
26259099
9.

[Prostate cancer of unknown primary origin with multiple lymph nodes metastasis; a case report].

Haraoka M, Takamuki M, Toyonaga Y, Tanaka M, Hanazawa K, Sakamoto Y, Horie S.

Nihon Hinyokika Gakkai Zasshi. 2014 Oct;105(4):212-7. Japanese.

PMID:
25757353
10.

Nationwide survey of the development of drug resistance in the pediatric field in 2007, 2010, and 2012: drug sensitivity of Haemophilus influenzae serotype b strain in Japan.

Baba H, Sato Y, Toyonaga Y, Hanaki H, Sunakawa K.

J Infect Chemother. 2015 Apr;21(4):277-83. doi: 10.1016/j.jiac.2014.12.006. Epub 2014 Dec 26.

PMID:
25618776
11.
12.

Genetic analysis of a pediatric clinical isolate of Moraxella catarrhalis with resistance to macrolides and quinolones.

Iwata S, Sato Y, Toyonaga Y, Hanaki H, Sunakawa K.

J Infect Chemother. 2015 Apr;21(4):308-11. doi: 10.1016/j.jiac.2014.11.002. Epub 2014 Nov 14.

PMID:
25481761
13.

Analysis of prostate cancer localization toward improved diagnostic accuracy of transperineal prostate biopsy.

Sakamoto Y, Fukaya K, Haraoka M, Kitamura K, Toyonaga Y, Tanaka M, Horie S.

Prostate Int. 2014 Sep;2(3):114-20. doi: 10.12954/PI.14052. Epub 2014 Jun 17.

14.

Brush cytology of acinar cell carcinoma of the pancreas with intraductal growth: a case report.

Toyonaga Y, Yamazaki K, Yamada M, Koyasu T, Koyama Y, Ishida Y.

Diagn Cytopathol. 2014 Apr;42(4):321-4. doi: 10.1002/dc.23087. Epub 2013 Dec 20.

PMID:
24376257
15.

JTK-853, a novel non-nucleoside hepatitis C virus polymerase inhibitor, demonstrates a high genetic barrier to resistance in vitro.

Ando I, Ogura N, Toyonaga Y, Hirahara K, Shibata T, Noguchi T.

Intervirology. 2013;56(5):302-9. doi: 10.1159/000351141. Epub 2013 Jul 5.

16.

Stone attenuation value and cross-sectional area on computed tomography predict the success of shock wave lithotripsy.

Tanaka M, Yokota E, Toyonaga Y, Shimizu F, Ishii Y, Fujime M, Horie S.

Korean J Urol. 2013 Jul;54(7):454-9. doi: 10.4111/kju.2013.54.7.454. Epub 2013 Jul 15.

17.

Primary effusion lymphoma-like lymphoma unrelated to human herpesvirus 8 with aggressive clinical course in patient receiving cyclosporine.

Yamazaki K, Toyonaga Y, Itokawa T, Koyama Y, Ishida Y.

J Clin Oncol. 2013 Nov 1;31(31):e435-8. doi: 10.1200/JCO.2012.46.8058. Epub 2013 Jun 17. No abstract available.

PMID:
23775963
18.

Nationwide survey of the development of drug-resistant pathogens in the pediatric field in 2007 and 2010: drug sensitivity of Streptococcus pneumoniae in Japan (second report).

Tajima T, Sato Y, Toyonaga Y, Hanaki H, Sunakawa K.

J Infect Chemother. 2013 Jun;19(3):510-6. doi: 10.1007/s10156-013-0593-x. Epub 2013 Apr 7.

19.

Nationwide survey of the development of drug resistance in the pediatric field in 2007 and 2010: drug sensitivity of Haemophilus influenzae in Japan (second report).

Hoshino T, Sato Y, Toyonaga Y, Hanaki H, Sunakawa K; Drug-Resistant Pathogen Surveillance Group in Pediatric Infectious Disease.

J Infect Chemother. 2013 Jun;19(3):495-503. doi: 10.1007/s10156-013-0591-z. Epub 2013 Apr 7.

20.

Genotypic and phenotypic analyses of hepatitis C virus from patients treated with JTK-853 in a three-day monotherapy.

Ogura N, Toyonaga Y, Ando I, Hirahara K, Shibata T, Turcanu G, Pai S, Yee K, Gerhardt B, Rodriguez-Torres M, Noguchi T.

Antimicrob Agents Chemother. 2013 Jan;57(1):436-44. doi: 10.1128/AAC.01432-12. Epub 2012 Nov 5.

21.

Preclinical characterization of JTK-853, a novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.

Ando I, Adachi T, Ogura N, Toyonaga Y, Sugimoto K, Abe H, Kamada M, Noguchi T.

Antimicrob Agents Chemother. 2012 Aug;56(8):4250-6. doi: 10.1128/AAC.00312-12. Epub 2012 May 21.

22.

Nationwide survey of the development of drug-resistance in the pediatric field: drug sensitivity of Haemophilus influenzae in Japan.

Sakata H, Toyonaga Y, Sato Y, Hanaki H, Nonoyama M, Oishi T, Sunakawa K.

J Infect Chemother. 2009 Dec;15(6):402-9. doi: 10.1007/s10156-009-0729-1.

PMID:
20012732
23.

Nationwide survey of the development of drug-resistant pathogens in the pediatric field: drug sensitivity of Streptococcus pneumoniae in Japan.

Sato Y, Toyonaga Y, Hanaki H, Nonoyama M, Oishi T, Sunakawa K.

J Infect Chemother. 2009 Dec;15(6):396-401. doi: 10.1007/s10156-009-0723-7.

PMID:
20012731
24.
25.

Heterogeneous selection at specific loci in natural environments in Arabidopsis thaliana.

Weinig C, Dorn LA, Kane NC, German ZM, Halldorsdottir SS, Ungerer MC, Toyonaga Y, Mackay TF, Purugganan MD, Schmitt J.

Genetics. 2003 Sep;165(1):321-9.

26.

[Pharmacokinetic and clinical studies on teicoplanin for sepsis by methicillin-cephem resistant Staphylococcus aureus in the pediatric and neonate field].

Sunakawa K, Nonoyama M, Fujii R, Iwai N, Sakata H, Shirai M, Sato T, Kajino M, Toyonaga Y, Sano T, Naito A, Minagawa K, Niida Y, Oda T, Yokozawa M, Asanuma H, Shimura K, Fujimura M, Kitajima H, Fujinami K, Numazaki K, Fujikawa T, Kobayashi Y, Sato Y, Nishimura T, Iwata S, Tsuchihashi N, Oishi T, Matsumoto S, Motohiro T, Osawa M, Sunahara M, Shirakawa S, Nishida H, Takahashi N, Nakano R, Sai N, Iyoda K, Yoshimitsu K, Ogawa K, Okazaki T, Tsukimoto I, Motoyama O, Takada Y, Kawasaki M, Sunaoshi W, Nakamura S, Ueda Y, Kamata M, Kato T, Chiba M, Ouchi K, Sato S, Horiuchi T, Suzuki K, Shimoyama T, Masaki H, Aikyo M, Kawada M, Banba M, Furukawa S, Okada T, Yamaguchi S, Hirota O, Koizumi S, Wada H, Ohta K, Uehara T, Yukitake K, Mori T, Takakuwa S, Matsuyama K.

Jpn J Antibiot. 2002 Oct;55(5):656-77. Japanese.

PMID:
12532639
27.

Novel loci control variation in reproductive timing in Arabidopsis thaliana in natural environments.

Weinig C, Ungerer MC, Dorn LA, Kane NC, Toyonaga Y, Halldorsdottir SS, Mackay TF, Purugganan MD, Schmitt J.

Genetics. 2002 Dec;162(4):1875-84.

28.

[Influence of dexamethasone on the clinical course of bacterial meningitis in children. Especially on secondary fever. Experiences in 27 institutions].

Kobayashi Y, Sunakawa K, Fujita K, Saijo M, Murono K, Sakata H, Maruyama S, Inyaku F, Toyonaga Y, Iwata S, Meguro H, Terashima I, Ishikawa N, Oshima N, Uehara S, Nakamura A, Kurosaki T, Kamoshita N, Ohkawa S, Shimizu M, Ozaki A, Fukuoka K, Akita H, Yokota T, Fujii R, et al.

Kansenshogaku Zasshi. 1999 Jul;73(7):664-74. Japanese.

PMID:
10481402
29.

[Clinical and bacteriological evaluation of ceftriaxone (CTRX) dosed once daily in children with community-acquired pneumonia].

Toyonaga Y, Kanemura H, Kitano M, Mitsui Y, Ishihara T, Hoshiai M, Ohno R.

Jpn J Antibiot. 1999 Apr;52(4):322-32. Japanese.

PMID:
10396689
30.

Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics.

Nishijima T, Saito Y, Aoki A, Toriya M, Toyonaga Y, Fujii R.

J Antimicrob Chemother. 1999 May;43(5):637-43.

PMID:
10382884
31.

[Pharmacokinetic and clinical evaluation of tazobactam/piperacillin in the pediatric field].

Toyonaga Y, Ishihara T, Tezuka T, Nakamura H.

Jpn J Antibiot. 1998 May;51(5):325-45. Japanese.

PMID:
9693966
32.

[Antimicrobial activities of cefcapene against clinical isolates from respiratory tract infections of outpatients].

Ishihara R, Ishii Y, Suzuki Y, Nakazawa A, Deguchi K, Toyonaga Y.

Jpn J Antibiot. 1998 Jan;51(1):1-10. Japanese.

PMID:
9557272
33.

[Trend of bacterial meningitis in children over a 14 year period (1981 through 1994) in Japan--an analysis based on studies in 27 institutions].

Kobayashi Y, Sunakawa K, Fujita K, Saijo M, Murono K, Sakata H, Maruyama S, Inyaku F, Toyonaga Y, Iwata S, Meguro H, Terashima I, Ishikawa N, Oshima N, Uehara S, Nakamura A, Kurosaki T, Kamoshita N, Ohkawa S, Shimizu M, Ozaki A, Fukuoka K, Akita H, Yokota T, Fujii R.

Kansenshogaku Zasshi. 1997 Oct;71(10):1017-24. Japanese.

PMID:
9394553
34.

[Clinical evaluation of faropenem against infections in pediatric fields].

Sunakawa K, Satoh Y, Iwata S, Terashima I, Meguro H, Kusumoto Y, Kato T, Akita H, Goshima T, Yokota T, Toyonaga Y, Ishihara T, Kanemura H, Iwai N, Nakamura H, Nakashima M.

Jpn J Antibiot. 1997 Sep;50(9):739-55. Japanese.

PMID:
9394235
35.

[Pharmacokinetic and clinical studies with cefluprenam in the pediatric field. Pediatric Study Group of Gefluprenam].

Fujii R, Abe T, Tajima T, Kobayashi M, Terashima I, Meguro H, Sunakawa K, Yokota T, Akita H, Kusumoto Y, Iwata S, Satoh Y, Toyonaga Y, Ishihara T, Nakamura H, Iwai N, Nakamura H, Kuno K, Katoh T, Ogawa A, Itomi K, Okumura A, Hayakawa F, Takahashi H, Etoh M, et al.

Jpn J Antibiot. 1997 Jul;50(7):597-621. Japanese.

PMID:
9743906
36.

Pharmacokinetics of antibiotics in children.

Toyonaga Y.

Acta Paediatr Jpn. 1997 Feb;39(1):114-23.

PMID:
9124043
37.

[Pharmacokinetic and clinical evaluation of azithromycin using fine granules or capsules in the pediatric patients].

Toyonaga Y, Ishihara T, Nakamura H.

Jpn J Antibiot. 1996 Nov;49(11):981-93. Japanese.

PMID:
8988410
38.

[Criteria for the clinical evaluation of antimicrobial drugs in neonates].

Fujii R, Sato Y, Kobayashi H, Nishimura T, Sunagawa K, Iwata K, Meguro E, Toyonaga Y, Akita H, Iwai N, Motohiro K, Sato H.

Jpn J Antibiot. 1996 Jul;49(7):743-53. Japanese. No abstract available.

PMID:
8828074
39.

[Optimum dose study of cefozopran in the pediatric field].

Fujii R, Sunakawa K, Sato Y, Yokota T, Yoshimura K, Kondoh Y, Kawaoi Y, Terashima I, Meguro H, Niinou K, Toyonaga Y, Ishihara T, Iwai N, Nakamura H, Kuno K, Miyajima Y, Sakurai M, Itoh M, Kawasaki H, Suga S, Kamiya H, Fujiwara T, Inui T, Taniguchi K, Nakayama M, et al.

Jpn J Antibiot. 1996 Jul;49(7):663-77. Japanese.

PMID:
8828069
40.

[Bacteriological, pharmacokinetic and clinical studies of SY5555 dry syrup in the pediatric field].

Toyonaga Y, Ishihara T, Tezuka T, Nakamura H.

Jpn J Antibiot. 1995 Jan;48(1):71-91. Japanese.

PMID:
7699846
41.

[Pharmacokinetic and clinical evaluation of cefozopran in the pediatric field].

Toyonaga Y, Ishihara T, Hatakeyama K, Sano T, Kawamura K, Seo K, Nakamura H.

Jpn J Antibiot. 1994 Nov;47(11):1495-513. Japanese.

PMID:
7853680
42.

[Pharmacokinetic and clinical studies of SY5555 in the pediatric field. Pediatric Study Group of SY5555].

Fujii R, Abe T, Tajima T, Terashima I, Meguro H, Sato H, Niino K, Suzuki H, Toyonaga Y, Nakamura H, et al.

Jpn J Antibiot. 1994 Apr;47(4):383-408. Japanese.

PMID:
8201768
43.

[Pharmacokinetic and clinical studies of S-1108 in the pediatric field].

Toyonaga Y, Ishihara T, Tezuka T, Sano T, Nakamura H.

Jpn J Antibiot. 1993 Nov;46(11):991-1002. Japanese.

PMID:
8309075
44.

[Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients].

Fujii R, Chiba S, Numazaki K, Mori T, Terashima I, Meguro H, Mori A, Toyonaga Y, Sunakawa K, Satoh Y, et al.

Jpn J Antibiot. 1993 Oct;46(10):926-37. Japanese. Erratum in: Jpn J Antibiot 1994 Sep;47(9):1240.

PMID:
8254895
45.

[Criteria for clinical evaluation of antibiotics in pediatrics. The purpose and process for establishing the criteria].

Fujii R, Kobayashi Y, Nishimura T, Sunakawa K, Iwata S, Meguro H, Toyonaga Y, Akita H, Kuno K, Iwai N, et al.

Jpn J Antibiot. 1993 Aug;46(8):736-47. Japanese.

PMID:
8230741
46.

[Bacteriological, pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field].

Toyonaga Y, Ishihara T, Sano T, Tezuka T, Nakamura H.

Jpn J Antibiot. 1993 Jul;46(7):604-28. Japanese.

PMID:
8371496
47.

[Judgment criteria in clinical tests for antibacterial agents used in pediatrics].

Fujii Y, Kobayashi H, Nishimura T, Sunakawa K, Iwata T, Meguro E, Toyonaga Y, Akita H, Hisano K, Iwai N, et al.

Jpn J Antibiot. 1993 May;46(5):411-20. Japanese. No abstract available.

PMID:
8326681
48.

[Pharmacokinetic and clinical studies on meropenem].

Toyonaga Y, Yamori K, Hatakeyama K, Ishihara T, Kawamura K, Seo K, Nakamura H, Okabe N, Toyoda S, Katayama A, et al.

Jpn J Antibiot. 1992 Jul;45(7):850-65. Japanese.

PMID:
1522677
49.

[Pharmacokinetic and clinical studies on panipenem/betamipron in the pediatric field].

Toyonaga Y, Yamori K, Hatakeyama K, Kawamura K, Seo K, Hori M.

Jpn J Antibiot. 1992 Mar;45(3):329-51. Japanese.

PMID:
1512930
50.

[Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field].

Toyonaga Y, Hatakeyama K, Yamori K, Sakaguchi N, Nakano K, Yamazaki M, Sugita M, Hori M.

Jpn J Antibiot. 1992 Jan;45(1):48-73. Japanese.

PMID:
1495196

Supplemental Content

Loading ...
Support Center